Power Law company profile

Accolade

Health Tech & Medtech · Plymouth Township, United States · Founded 2007 · IPO 2020 Unicorn

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation

$576M

Market cap · 2026

Revenue

$414M

Latest reported FY

Investors

7 investors on Accolade's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Series A 2 investors entered at this stage

Humana

Accretive

Series B+ 5 investors entered at this stage

Andreessen Horowitz

Comcast Ventures

McKesson Ventures

Madrona Venture Group

Carrick Capital Partners

Global footprint

Where Accolade has talent and traffic

AI talent share

0.6% of workforce is AI talent
(9 of 1,422 staff)

Core AI20.14%

Other AI70.49%

Non-AI workforce1,41399.37%

Web traffic by country

130K monthly visits
across markets

🇺🇸 United States84.7%

🇨🇦 Canada7%

🇦🇺 Australia1.4%

🇬🇧 United Kingdom1.2%

🇮🇳 India1%

Top 5 markets shown

Patent intelligence

$2M patent portfolio · 4 active families

Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.

Estimated portfolio value

$2M

0.28% of market cap · 95.9× smaller than top peer Fitbit ($154M)

4 active patent families

Where Accolade innovates Computer scienceMedical treatmentSAPS IIPhysician referralInfection rate

Above peer median on Legal, Strategic, Market, Economic, Technology

Quality vs same-sector peers

Accolade on the five Patsnap quality dimensions

Accolade in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.

Compare against

Patent quality scores (0–100)

Source: Dealroom Patent Intelligence · Patsnap

Tech-focus vs peers

Where Accolade concentrates inside the peer cluster

Axes are the most-shared Patsnap topics across Accolade and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).

Compare against

Top-topic prominence (rank inverted, 0–100)

Source: Dealroom Patent Intelligence · Patsnap top-10 topics per company

This is teaser data. The full per-sub-category breakdown, individual patent records, and quality-score history are on the Dealroom platform — request a demo to access.

See Accolade on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo